Complement Therapeutics GmbH (CTx) is a German headquartered early-stage biotech focused on the research and development of novel therapeutics for complement-mediated diseases. CTx is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade.
CTx lead investigational product (CTx001) is being evaluated as a potential gene therapy for Geographic Atrophy, a leading cause of blindness.
Location: United Kingdom, England, London
Total raised: $84.66M
Founders name: Richard Unwin; Simon J. Clark
Investors 5
Date | Name | Website |
- | Panakes Pa... | panakes.it |
25.02.2022 | BioGenerat... | biogenerat... |
- | Forbion | forbion.co... |
21.04.2023 | GIMV | gimv.com |
18.05.2023 | Cambridge ... | cic.vc |
Funding Rounds 2
Persons 5
Date | First Name | Last Name | Title | Location | |||
- | Simon | J. Clark | Co-Founder | linkedin.c... | - | s*********... | - |
- | Harry | Kwong | Associate ... | linkedin.c... | - | h*********... | - |
- | Rafiq | Hasan | Chief Exec... | linkedin.c... | - | r***q@comp... | - |
- | Mustafa | Munye | - | linkedin.c... | - | m*****a@co... | - |
- | Richard | Unwin | Co-Founder | linkedin.c... | - | r*****d@co... | - |
Mentions in press and media 15
Date | Title | Description | Source |
10.11.2023 | Complement Therapeutics Enrols First US Participant in the N... | Munich, Germany. 9 November 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnol... | seroba-lif... |
09.11.2023 | Complement Therapeutics Enrols First US Participant | Complement Therapeutics Enrols First US Participant in the Non-interventional i-GAIN Study of People... | hadeanvent... |
02.10.2023 | 'The fundamentals are really strong': Why investors are stay... | While the biotech bull market hasn’t charged back in 2023 as many had hoped, European-focused ventur... | fiercebiot... |
05.08.2023 | Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chi... | Munich, Germany. 2 August 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnolog... | seroba-lif... |
11.05.2023 | Il mercato del Venture Capital ad aprile 2023 | Come è andato il mercato del Venture Capital ad aprile 2023? Facciamo insieme una carrellata delle s... | startup-ne... |
08.05.2023 | London-based startups that raised over €10M in April 2023; 1... | London’s startup ecosystem continues to flourish, attracting investors from around the globe and fos... | siliconcan... |
27.04.2023 | Complement Therapeutics appoints Dominic Moreland as Chief F... | Complement Therapeutics appoints Dominic Moreland as Chief Financial Officer Complement Therapeutic... | cic.vc/new... |
18.04.2023 | Complement Therapeutics Secures €72 Million in Series A Fina... | Munich, Germany. 17 April 2023. Complement Therapeutics GmbH (CTx), a preclinical stage biotechnolog... | seroba-lif... |
17.04.2023 | Complement Therapeutics Secures €72 Million in Series A Fina... | Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Target... | hadeanvent... |
17.04.2023 | VCs 'Complement' European biotech with $79M for retinal AAV ... | VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year Endpoints ... | cic.vc/new... |
Show more